The cardiac enigma: current conundrums in heart failure research [version 1; referees: 3 approved]
The prevalence of heart failure is expected to increase almost 50% in the next 15 years because of aging of the general population, an increased frequency of comorbidities, and an improved survival following cardiac events. Conventional treatments for heart failure have remained largely static over...
Main Authors: | Michael S. Kapiloff, Craig A. Emter |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2016-01-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/5-72/v1 |
Similar Items
-
Spironolactone in cardiovascular disease: an expanding universe? [version 1; referees: 2 approved]
by: John W. Funder
Published: (2017-09-01) -
Novel approaches for treating hypertension [version 1; referees: 2 approved]
by: Andrew J. Freeman, et al.
Published: (2017-01-01) -
Recent advances in treatment of heart failure [version 1; referees: 2 approved]
by: Takeshi Kitai, et al.
Published: (2015-12-01) -
Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy [version 1; referees: 3 approved]
by: Lama Ghazi, et al.
Published: (2017-03-01) -
Acute Coronary Syndromes in the Elderly [version 1; referees: 3 approved]
by: Niels Engberding, et al.
Published: (2017-10-01)